rs198389

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000945854.1(NPPB):​c.-381T>C variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 152,080 control chromosomes in the GnomAD database, including 12,025 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12025 hom., cov: 32)

Consequence

NPPB
ENST00000945854.1 upstream_gene

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.51

Publications

100 publications found
Variant links:
Genes affected
NPPB (HGNC:7940): (natriuretic peptide B) This gene is a member of the natriuretic peptide family and encodes a secreted protein which functions as a cardiac hormone. The protein undergoes two cleavage events, one within the cell and a second after secretion into the blood. The protein's biological actions include natriuresis, diuresis, vasorelaxation, inhibition of renin and aldosterone secretion, and a key role in cardiovascular homeostasis. A high concentration of this protein in the bloodstream is indicative of heart failure. The presence of myocardial injury is a significant predictor of mortality in hospitalized coronavirus disease 2019 (COVID-19) patients, and there is evidence of increased levels of natriuretic peptide B in hospitalized non-survivor COVID-19 patients. The protein also acts as an antimicrobial peptide with antibacterial and antifungal activity. Mutations in this gene have been associated with postmenopausal osteoporosis. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000945854.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.474 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000945854.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPPB
ENST00000945854.1
c.-381T>C
upstream_gene
N/AENSP00000615913.1

Frequencies

GnomAD3 genomes
AF:
0.392
AC:
59573
AN:
151962
Hom.:
12003
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.407
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.404
Gnomad EAS
AF:
0.179
Gnomad SAS
AF:
0.490
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.419
Gnomad OTH
AF:
0.398
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.392
AC:
59635
AN:
152080
Hom.:
12025
Cov.:
32
AF XY:
0.390
AC XY:
28982
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.408
AC:
16936
AN:
41492
American (AMR)
AF:
0.284
AC:
4346
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.404
AC:
1400
AN:
3464
East Asian (EAS)
AF:
0.179
AC:
927
AN:
5174
South Asian (SAS)
AF:
0.490
AC:
2368
AN:
4828
European-Finnish (FIN)
AF:
0.369
AC:
3909
AN:
10582
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.419
AC:
28488
AN:
67946
Other (OTH)
AF:
0.397
AC:
840
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1902
3804
5705
7607
9509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
50171
Bravo
AF:
0.383
Asia WGS
AF:
0.354
AC:
1229
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.090
DANN
Benign
0.28
PhyloP100
-3.5
PromoterAI
0.37
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs198389;
hg19: chr1-11919271;
COSMIC: COSV64687424;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.